可见光诱导的迪塞利尼德交联聚合物微粒用于ROS触发的药物输送
Xinfeng Cheng1, Huixian Li1, Xiaomeng Sun1
1College of Chemistry and Pharmaceutical Engineering, Nanyang Normal University, Nanyang 473061, China.
Molecules (Basel, Switzerland)
|August 29, 2024
概括
研究人员开发了新的可见光交联聚氨微粒,用于控制药物输送. 这些小粒在响应活性氧物种 (ROS) 时按需释放多克索鲁比 (DOX),显示出癌症治疗的前景.
科学领域:
- 聚合物化学 聚合物化学
- 纳米技术 纳米技术
- 生物医学工程 生物医学工程
背景情况:
- 开发用于控制药物输送的多功能纳米平台至关重要.
- 反应性氧物种 (ROS) 是癌症治疗的关键目标.
- 可见光触发的交叉连接在纳米医学中提供了时空控制.
研究的目的:
- 设计和合成可见光诱导的disenide-crosslinked聚氨微粒.
- 评估它们作为多克索鲁比 (DOX) 的ROS触发药物递送系统的潜力.
- 评估微粒的稳定性,药物释放概况和细胞毒性.
主要方法:
- 合成了一种两性块共聚合物 (PEG-b-PUSe-b-PEG) 与迪塞伦基.
- 自组装成小粒,并封装DOX.
- 可见光触发的微细胞核通过Se-Se键转化在位交联.
- 在不同的条件下,粒子大小,体稳定性和体外药物释放的表征.
- 使用MTT测定和细胞吸收研究进行细胞毒性评估.
主要成果:
- 与非交叉连接的小粒 (NCLM) 相比,disenide交叉连接的小粒 (CLM) 显示出较小的颗粒大小和增强的体稳定性.
- 在生理条件下,CLM表现出抑制的DOX释放,但在氧化环境中触发了突发释放.
- 交叉连接的聚氨菌根对HeLa细胞没有显著的细胞毒性.
- 观察到有效的细胞吸收和细胞内DOX释放.
结论:
- 可见光诱导的disenide-crosslinked聚氨小粒代表了一个有前途的ROS响应药物递送系统.
- 可逆交叉连接机制允许按需释放药物.
- 这个平台具有针对性癌症治疗的巨大潜力.
相关概念视频
Modified-Release Drug Delivery Systems: Stimuli-Activated
175
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
175
Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
Site-Targeted Drug Delivery Systems: Polymeric Carriers
159
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
159


